In a prospective cohort study, associations of resting heart rate with risk of coronary, cardiovascular disease, cancer, and all-cause mortality in age-specific cohorts of black and white men and women were examined over 22 years of follow-up. Participants were employees from 84 companies and organizations in the Chicago, Illinois, area who volunteered for a screening examination. Participants included 9,706 men aged 18-39 years, 7,760 men aged 40-59 years, 1,321 men aged 60-74 years, 6,928 women aged 18-39 years, 6,915 women aged 40-59 years, and 1,151 women aged 60-74 years at trie baseline examination in [1967][1968][1969][1970][1971][1972][1973]. Vital status was ascertained through 1992. For fatal coronary disease, multivariate-adjusted relative risks associated with a 12 beats per minute higher heart rate (one standard deviation) were as follows: for men aged 18-39 years, relative risk (RR) = 1.27 (95% confidence interval (Cl) 1.08-1.48); for men aged 40-59 years, RR = 1.13 (95% Cl 1.05-1.21); for men aged 60-74 years, RR = 1.00 (95% Cl 0.89-1.12); for women aged 40-59 years, RR = 1.21 (95% Cl 1.07-1.36); and for women aged 60-74 years, RR = 1.16 (95% Cl 0.99-1.37). Corresponding risks for all fatal cardiovascular diseases were similar to those for coronary death alone. Deaths from cancer were significantly associated with heart rate in men and women aged 40-59 years. All-cause mortality was associated with higher heart rate in men aged 18-39 years (RR = 1.11, 95% Cl 1.01-1.20), men aged 40-59 years (RR = 1.16, 95% Cl 1.11-1.21), and women aged 40-59 years (RR = 1.20, 95% Cl 1.13-1.27). Heart rate was not associated with mortality in women aged 18-39 years. In summary, heart rate was a risk factor for mortality from coronary disease, all cardiovascular diseases, and all causes in younger men and in middle-aged men and women, and for cancer mortality in middle-aged men and women. Am J Epidemiol 1999;149:853-62. cardiovascular diseases; coronary disease; heart rate; mortality; neoplasms; prospective studies; risk factors
In humans, several long term cohort studies have found resting heart rate to be a risk factor for mortality from coronary heart disease, cardiovascular diseases, cancer, or all causes (1) (2) (3) (4) (5) (6) (7) (8) . Some prior reports have been limited to men (1, 2, 4, 5, 8) , and most were restricted to specific age groups, typically persons who were middle-aged at baseline examination. In a few reports, heart rate was not found to be a risk factor for mortality after adjustment for multiple covariates (3, 7, 8) . Thus, the role of resting heart rate as a risk factor in humans remains incompletely examined in a wide range of ages and in both sexes.
Heart rate as an independent risk factor for mortality was investigated with use of data from the Chicago Heart Association Detection Project in Industry, a large prospective study providing mortality data for agespecific cohorts of both women and men. In this set of analyses, we stratified the data by sex and age to determine the relation of resting heart rate to mortality in women and men aged 18-39, 40-59, and 60-74 years at baseline, and we controlled for multiple possible confounding variables.
MATERIALS AND METHODS

Population
Between November 1967 and January 1973, the Chicago Heart Association Detection Project in Industry screened 39,573 women and men of varied ethnicities in 84 cooperating companies and organizations in the Chicago, Illinois, area. All employees in the labor force, totaling approximately 75,000 people, were invited to participate regardless of type of job or shift worked. The volunteer rate for this screening effort was 53 percent.
Survey methods
Details on the standardized methods used in the Chicago Heart Association field examination have been given elsewhere (9) . In brief, trained staff (nurses and technicians) measured height, weight, supine blood pressure (a single casual reading using a standard mercury sphygmomanometer), serum total cholesterol (nonfasting blood sample), plasma glucose level (1 hour after a 50-g oral glucose load), and serum uric acid level, and took a resting electrocardiogram. A selfadministered questionnaire was used to collect demographic data, smoking history, and information on previous medical diagnoses and treatments (e.g., clinical diagnosis of hypertension or diabetes mellitus).
Resting electrocardiograms were recorded with the participant lying supine following a minimum rest period of 5 minutes. All electrocardiograms were read by one cardiologist using the criteria and forms of the 1960-1962 National Health Examination Survey (10) . Tracings with any abnormality were later identified and reclassified according to the Minnesota code (11) . Electrocardiographic abnormalities were classified as major or minor based on the criteria of the Pooling Project Research Group (12) .
During the first years of screening, resting heart rate was determined to the nearest beat per minute by measuring the interval between R waves for three consecutive QRS complexes recorded on the electrocardiogram. In the later years of screening, a heart rate meter attached to skin electrodes performed the same measurement electronically and provided a digital reading. During a brief middle phase, heart rate was not systematically measured. Participants screened during this interim phase were excluded from these analyses.
Exclusions
A total of 5,792 participants were excluded, for the following reasons: data were missing upon follow-up (n = 100); the participants were outside of the age range of the study, i.e., they were not aged 18-74 years (n = 190); information on heart rate was missing, as described above (n = 4,971); data on other relevant variables were missing (n = 435); and there was electrocardiographic evidence of prior myocardial infarction at baseline (n = 96). Thus, this report is based on 33,781 persons (18,787 men and 14,994 women) aged 18-74 years who were free of electrocardiographic evidence of prior myocardial infarction at baseline, with the following age breakdown: 9,706 men aged  18-39 years, 7,760 men aged 40-59 years, 1,321 men  aged 60-74 years, 6,928 women aged 18-39 years,  6,915 women aged 40-59 years, and 1,151 women aged 60-74 years.
Mortality endpoints
Vital status was ascertained through 1992, with a mean follow-up of 22 years. Deaths among cohort members were determined by several methods: before 1979, by direct mail, telephone, contact with the original employer, or matching of cohort records against Social Security Administration files; after 1979, by matching of study records against National Death Index records. Death certificates were obtained for known decedents, and multiple causes of death were coded by a physician according to the Eighth Revision of the International Classification of Diseases (ICD-8), adapted for use in the United States (13) . All coding decisions were cross-checked by study team members blinded to baseline data. For this report, only underlying cause of death was used. Coronary heart disease mortality was defined as ICD-8 codes 410.0-414.9, cardiovascular disease mortality as ICD-8 codes 400.0-445.9, and cancer mortality as ICD-8 codes 140.0-209.9.
Statistical analyses
Two types of analyses were conducted. In the first type, participants were subdivided into four strata based on heart rate (<70, 70-79, 80-89, and >90 beats per minute). For each of the six age/sex groups, ageadjusted mortality rates per 10,000 person-years of follow-up were computed for coronary heart disease, cardiovascular disease, cancer, and all-cause mortality. Mortality rates for the four heart rate strata were ageadjusted by the direct method for each age/sex cohort based on the overall age distribution for each age/sex cohort. In the second type of analysis, three proportional hazards (Cox) regression models were used to calculate relative risks of death associated with a difference of 12 beats per minute (approximately one standard deviation) in heart rate. Model 1 adjusted only for baseline age. Model 2 adjusted for age, education (years), race (black and nonblack), serum total cholesterol (mg/dl), cigarette smoking (cigarettes/day), body mass index (weight (kg)/height (m) 2 ), body mass index squared, clinical diagnosis of diabetes mellitus, and major and minor electrocardiographic abnormalities. Because heart rate can contribute directly to the pathogenesis of hypertension (14, 15) , blood pressure may be in the pathway of the relation between heart rate and mortality; therefore, model 2 analyses were performed without inclusion of blood pressure, to take into consideration the possibility of overadjustment. In a third model (model 3), all variables in model 2 were included plus systolic blood pressure (mmHg).
To determine whether the heart rate-mortality association was consistent over time, we fitted separate Cox regression analyses for all men and all women aged 18-74 years for the 1-to 11-year and > 12-year segments of follow-up time. This analysis could not be performed meaningfully for the six separate age/sex cohorts because of small numbers of deaths in several of these subgroups during the first 11 years of followup. Table 1 presents data on baseline variables for the six age-/sex-specific cohorts. Mean heart rate was similar across the three age groups in men and was lower with age in women. Blood pressure was higher with age in both men and women; as expected, serum cholesterol was higher with age in women only. The proportion of current smokers was lower in men and women aged 60-74 years than in persons aged 18-39 years and 49-59 years. On average, male smokers used more than one package of cigarettes per day, female smokers fewer. Proportions of men and women with electrocardiographic abnormalities, diabetes, and antihypertensive drug treatment increased with age.
RESULTS
Baseline descriptive statistics
Correlations of heart rate with other baseline variables are shown by age and sex in table 2. Heart rate was positively and significantly correlated with systolic and diastolic blood pressures and cigarette smoking in all age groups (p < 0.01). Education was inversely correlated with heart rate in men and women aged 18-39 years and 40-59 years (p < 0.01); this association could have been due to greater cigarette smoking by less educated persons. Correlations of heart rate with age, serum cholesterol, and body mass index were small and/or inconsistent.
Baseline heart rate and 22-year mortality
Age-adjusted mortality rates for coronary heart disease, cardiovascular disease, all cancers, and all causes were generally higher with higher heart rate in younger men and in middle-aged and older men and women (tables 3 and 4). With only eight coronary heart disease deaths and 17 cardiovascular disease deaths in women aged 18-39 years, rates in this age/sex group were unstable across the four heart rate strata. Tables 5-7 show the relation of a heart rate higher by 12 beats per minute to 22-year relative risks of death from coronary heart disease, cardiovascular disease, cancer, and all causes for age-specific cohorts of men and women, with adjustment for age only (model 1) and adjustment for age and other major risk factors and potentially confounding factors (models 2 and 3). Because of concern about overadjustment (see Coronary heart disease mortality. Significant independent positive associations of heart rate and 22-year coronary heart disease mortality were found in men aged 18-39 years and in men and women aged 40-59 years, with relative risks (model 2) of 1.27, 1.13, and 1.21, respectively, per 12 beats/minute higher heart rate. Women aged 60-74 years had a relative risk of 1.16 per 12 beats/minute difference in heart rate for fatal coronary disease. This increased risk, although similar to that for women aged 40-59 years, was-with the smaller sample size-of borderline statistical significance.
Cardiovascular disease mortality. For all cardiovascular disease mortality, significantly greater risk with higher heart rate was also found in younger men and in middle-aged men and women. Relative risks for fatal cardiovascular disease were 1.23, 1.10, and 1.22, respectively, in these three cohorts.
Cancer mortality. For cancer mortality, associations were significant for middle-aged men and women (relative risks were 1.20 and 1.15, respectively). Heart rate was not associated with risk of mortality due to cancer among younger or older men or women.
All-cause mortality. An increased risk of death from all causes with higher heart rate was observed in five of the six age/sex groups-i.e., for all groups except women aged 18-39 years (relative risks of 1.05-1.20). Results were significant for younger men and middle-aged men and women and were borderline significant for older men.
Relations of heart rate to risks of coronary heart disease mortality, all cardiovascular disease mortality, and all-cause mortality tended to be stronger in middle- , major and minor electrocarcSographlc abnormalities (no/yes), race (Hack/nonblack), and diabetes (no/yes). U Adjusted for variables listed in model 2 plus systolic blood pressure (rrunHg). # There were too few deaths In this category for estimation of the relative risk. aged women than in men (table 6) . However, the small differences in Cox coefficients between men and women were not statistically significant {t = 0.86-1.63; p = 0.39-0.10).
In general, associations were weaker with the inclusion of systolic blood pressure in the Cox model (i.e., model 3 as compared with model 2). Increased mortality risk for all endpoints with higher heart rate remained significant among women aged 40-59 years (table 6, model 3); results were significant for cancer and all-cause mortality in middle-aged men. Further adjustment for baseline plasma glucose and uric acid levels did not change the relative risks (data not shown).
Cox regression analyses were conducted separately for all men and all women aged 18-74 years for the first 11 years of follow-up and the subsequent 11 years of follow-up. In the two follow-up periods, respectively, there were 426 and 730 deaths from coronary disease, 541 and 996 deaths from all cardiovascular diseases, 335 and 751 deaths from cancer, and 1,149 and 2,235 deaths from all causes in men; there were 103 and 307 deaths from coronary disease, 145 and 481 deaths from all cardiovascular diseases, 240 and 484 deaths from cancer, and 487 and 1,206 deaths from all causes in women. Findings were consistent across the two time periods, with no evidence of weakening of the associations over time.
DISCUSSION
In this 22-year mortality follow-up study of six age-/ sex-specific cohorts of Chicago-area employed adults, a 12 beats/minute higher heart rate was significantly associated with increased risk of coronary heart disease and cardiovascular disease mortality in younger (aged 18-39 years) and middle-aged (aged 40-59 years) men and in middle-aged women. Higher resting heart rate was also an independent risk factor for cancer mortality in middle-aged men and women and for all-cause mortality in younger and middle-aged men and in middle-aged women. Heart rate was not found to be a significant independent risk factor for any of the causes of mortality analyzed here in older (aged 60-74 years) men or women. In addition, higher heart rate was not found to be a risk factor in the younger female cohort. Finally, risk relations were present in both the earlier (first 11 years) and the later (second 11 years) portions of the 22-year follow-up period. The findings extend observations on associations of resting heart rate to cardiovascular and noncardiovascular mortality that were previously reported from this cohort (1, 4, 8) and from other prospective studies (2, 3, (5) (6) (7) .
A previous report based on three male Chicago cohorts, including the largest of those cohorts reassessed here with longer follow-up (8) , demonstrated that resting heart rate was associated with increased risk of all cardiovascular and coronary disease mortality. In the prior report (8) , which was based on only 5 years of follow-up in 5,784 Chicago Heart Association men aged 45-64 years at baseline, positive associations between heart rate and mortality were attenuated or became nonsignificant after adjustment for covariates including age, systolic blood pressure, cigarette smoking, cholesterol, and body weight. A similar effect, whereby the risk association was attenuated after adjustment for major covariates, was observed in a Kaiser Permanente study (16) and in an Israeli cohort (17) . While the association between increased heart rate and cardiovascular disease endpoints weakened after multivariate adjustment in a Framingham Study report (3), the positive association of heart rate with death from coronary heart disease or all-cause mortality remained significant. A 1993 paper based on 7,735 men from the British Regional Heart Study (18) who were followed for 8 years reported results similar to those for Framingham men.
Few previous studies have examined the relation between heart rate and mortality in women. In two reports from the Framingham Study (3, 19) , heart rate was associated with total coronary disease death and sudden coronary disease death after adjustment for multiple coronary disease risk factors in men, but these relations were not confirmed in women. In the NHANES I Epidemiologic Follow-up Study (6) cohort, higher heart rate was associated with increased risk of cardiovascular and noncardiovascular mortality in both black men and white men. In that study, for black women, a resting heart rate of >84 beats per minute was associated with a threefold increase in risk of cardiovascular disease death. However, no significant increased risk with higher heart rate was observed in white women in the NHANES I Epidemiologic Follow-up Study. Thus, in the few previous studies that have included women, risks associated with higher heart rate in women have been uncertain because of variable results within and between studies. The variable results may be attributable to fundamental differences in the cohorts under study or to other undetermined factors, but a likely factor underlying the lack of association in several studies was smaller numbers of events due to shorter follow-up and/or smaller cohorts. This report from the Chicago Heart Association cohort included relatively large numbers of men and women. Thus, to our knowledge, this is the first long term cohort study to show similar multivariate-adjusted independent relations of increased heart rate to coronary, all cardiovascular disease, cancer, and all-cause mortality in middle-aged women and men.
As was shown here and elsewhere (20) (21) (22) (23) , heart rate is correlated with other cardiovascular disease risk factors, including systolic blood pressure, cigarette smoking, physical inactivity (18), levels of cholesterol (in other studies) and of important lipid fractions such as high density lipoprotein cholesterol (23), diabetes, insulin, uric acid, and general health status (2) . In this study and in some others (2, 5), associations of higher heart rate with mortality risks, both cardiovascular and noncardiovascular, remained significant after adjustment for multiple covariates. Indeed, adjustment for some covariates, particularly blood pressure, may represent overadjustment, since heart rate is a known risk factor for high blood pressure (14, 15, 21) and a common underlying mechanism may account for elevation of both measures (24) . Therefore, for the primary analyses here, we adjusted for age and other major covariates, but because of concern about possible overadjustment for blood pressure, our main conclusions are based on the model without adjustment for systolic blood pressure (model 2).
Several mechanisms for the coronary and cardiovascular disease findings are plausible. Animal studies have demonstrated that higher heart rate may be a causal factor in promoting atherosclerosis independent of blood pressure or blood lipids, presumably via a hemodynamic mechanism (25) (26) (27) . Nabel et al. (28) showed that elevated heart rate induced by pacing can cause coronary artery vasoconstriction in humans with atherosclerotic coronary disease, suggesting a means by which elevated heart rate can cause myocardial ischemia independent of its effect on myocardial oxygen demand. Thus, higher heart rate could increase cardiovascular mortality risk by accelerating atherosclerosis or, in coronary disease patients, both by increasing oxygen demand and by directly reducing myocardial blood flow (28) .
A limitation of some other reports on the role of heart rate in mortality risk has been short follow-up (8, 16, 17) . If higher resting heart rate represents a surrogate for poor cardiovascular health or poor general health, then associations seen in short term follow-up might disappear in later follow-up. On the other hand, if higher heart rate is causal, cardiovascular damage may accrue over many years, requiring long term follow-up to uncover adverse effects. Owing to the lengthy follow-up available in this large Chicago cohort, we were able to examine the impact of heart rate on mortality in two successive 11-year intervals. Positive associations seen in the overall 22-year follow-up period were found to occur in the first 11 years after the baseline examination, and they persisted in the second 11-year period (years [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Thus, these data, in contrast to those from shorter-term studies, provide increased confidence that the associations between elevated heart rate and mortality are not merely related to underlying poor health undetected by other means.
Because of the inability in this study (and in all observational research) to adjust for some plausible confounding variables, it is possible that higher resting heart rate is a surrogate for one or more unmeasured variables that may be causally linked to cardiovascular or noncardiovascular death. For example, Williams et al. (23) demonstrated associations between heart rate and certain lipoprotein subtractions that were not measured here. These included triglycerides, high density lipoprotein cholesterol, high density lipoprotein 3 mass, very low density lipoprotein mass, and low density lipoprotein mass (23) . Wannamethee and Shaper (2) also found correlations of resting heart rate with potential confounders that we did not measure, including forced expiratory volume (inverse relation), physical activity (inverse relation), and nonfasting triglyceride level. In the Williams et al. report (23) , approximately 30 percent of the variance in resting heart rate was attributed to the lipid subtractions listed above. Thus, it is conceivable that higher heart rate could be partly due to covariates, such as those listed, which we did not measure and could not adjust for in our analyses.
Higher heart rate was also associated with total cancer mortality, although the association was significant only in middle-aged men and women. An association between higher resting heart rate and total cancer mortality has been shown previously in all-male cohorts, including the Chicago Heart Association cohort reported on here in longer follow-up (1), two other Chicago cohorts (1), and a British cohort (5, 29) . Higher resting heart rate has been associated with prostate cancer mortality in men in a previous Chicago cohort report (4) , but the association of higher heart rate with prostate cancer incidence and mortality was not confirmed in a recent report from a large cohort of men examined in multiphasic checkups in the Kaiser Permanente system in California (30) . Higher heart rate has also been associated with colon cancer mortality in a male Hawaiian cohort (31) . Recently, Dekker et al. (32) found an association, also only in men, between total cancer mortality and reduced heart rate variability, a factor that is correlated with both higher resting heart rate and abnormal autonomic function. There do not appear to have been any prior reports Unking higher resting heart rate with cancer mortality in women, as described here. Because of limited data on women outside of this report, inconsistency of the association of heart rate with cancer in different age groups in this study, and the conflicting results in men concerning prostate cancer, further study of the relation between heart rate and cancer is warranted.
Several mechanisms might link mortality from various cancers to higher resting heart rate. For example, some cancers are believed to be directly under the influence of local neurotrophic factors associated with sympathetic nervous system activity. Prostate cancer is an example, and the prior report by Gann et al. (4) discusses this possibility at length. Frequent or regular exercise, which can reduce resting heart rate, has been linked to improved monocyte function (33) , which could protect against the development or spread of various cancers by improving cancer phagocytosis and killing. In some but not all studies (34) , regular exercise has been linked to a reduced risk of breast cancer (35) , possibly via suppression of endogenous estrogen secretion. Since exercise training can also lower resting heart rate, the association of regular exercise with reduced breast cancer risk could also be related to lower heart rate. Conversely, if higher heart rate is a marker of underlying "stress," then a putative association between stress and cancer mortality (36) could manifest itself through an elevated heart rate. Associations between cancer and heart rate may be worthy of further exploration, including the relation of resting heart rate to specific cancers (those already mentioned and others).
While the results presented here were positive, significant, and concordant for middle-aged men and women, findings in older men and women did not retain significance after multivariate adjustment It is unclear from these data whether heart rate associations attenuate with age because of changes in biology or simply because of smaller numbers of older people in the cohorts, resulting in loss of statistical power. Moreover, the meaning of resting heart rate in older people is complex, since elevated resting heart rate can be a marker for underlying diseases of various types (37) . On the other hand, slow heart rate can also be a marker for cardiovascular disease, especially sinus node dysfunction in older people, and a cardiac risk factor in the elderly (38) .
Results of this study, along with those of some others published previously, lend strong support to the concept that higher heart rate within the "normal" range in humans is a risk factor for coronary, cardiovascular, cancer, and all-cause mortality in both middle-aged women and men and younger men. Associations remained significant after adjustment for multiple covariates and were present in both shorter-and longerterm follow-up. The data are consistent with studies in both animals and humans suggesting that a causal role for increased heart rate in cardiovascular disease is biologically plausible (25) (26) (27) .
In terms of therapeutic or preventive implications, these observations might help explain a protective effect of regular exercise (39, 40) and of heart rateslowing medications in the primary and/or secondary prevention of cardiovascular disease (41) (42) (43) (44) (45) . Aerobic exercise training can be advocated for a multitude of reasons as a preventive approach to cardiovascular disease, cancer, and all-cause mortality (39, 40) . On the other hand, a possible preventive role for drugs that reduce heart rate in apparently healthy people requires further study before this practice can be advocated. These data from humans, combined with observations in mammalian species suggesting that resting heart rate correlates with life expectancy (46) , raise the provocative idea that various means of slowing heart rate might be useful in prolonging life.
